MedTrace Logo

A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB)

NCT00254566 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 398

Last updated 2009-11-11

Study results available
· View outcomes & findings →

Summary

This trial is a research drug study to compare the effects of two antibiotics for the treatment of acute exacerbation of chronic bronchitis

Conditions

  • Chronic Bronchitis

Interventions

OTHER

Moxifloxacin Placebo

1 capsule once daily for 5 days

DRUG

Moxifloxacin

1 X 400mg capsule once daily for 5 days

OTHER

Azithromycin SR Placebo

single dose, oral.

DRUG

Azithromycin SR

single dose 2.0 g oral

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • China
  • Malaysia
  • Philippines
  • Singapore
  • Taiwan
  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00254566 on ClinicalTrials.gov